DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE ESTIMATION OF NEFOPAM HYDROCHLORIDE IN POLYMETHACRYLATE NANOSPHERES
Objective: To develop and validate simple, sensitive, accurate, specific, precise, rugged, robust and reproducible UV spectrophotometry method for the quantitative estimation of Nefopam hydrochloride (NFH) loaded in polymethacrylate nanospheres (NFH-NS) as per ICH guidelines.
Methods: Polymethacrylate nanospheres of NFH were fabricated by quasi-solvent diffusion technique. The analytical method used phosphate buffer, pH 7.4 as a solvent for the estimation of NFH which has the absorption maxima (Î»max) value 266 nm. The calibration curve was plotted for NFH in beer's range of 50-400 Î¼g/ml. linear regression of calibration curve was performed by Graph Pad Prism version 5.01 for windows to find a p-value of the regression coefficient. The amount of NFH in polymethacrylate nanospheres (NFH-NS) was analyzed spectrophotometrically using regression equation obtained from the calibration curve. The analytical method was validated for linearity, range, accuracy, specificity, precision, ruggedness and robustness. Sandell's sensitivity value was determined for validation of sensitivity. The drug content of polymethacrylate nanospheres (NFH-NS) was estimated using regression equation.
Results: Polymethacrylate nanospheres of NFH were successfully fabricated by quasi-solvent diffusion technique. Regression equation obtained from calibration curve was y = 0.002x+0.001. The estimated amount of NFH in 50 mg of NFH-NS analyzed by UV spectrophotometry using regression equation was found 10.19 mg. Developed analytical method for NFH was found linear in the concentration range of 50-400 Î¼g/ml with high correlation coefficient of 0.9994 with p-value 0.008325 (*p<0.05). Molar absorptivity (Îµ), sandell's sensitivity and best-fit value slope was found to be 2.5 Ã— 10-3, 0.115 and 0.002509Â±0.00002569, respectively. Mean percentage recovery was found in accepted limit of 98%-102% which validated the accuracy of the method. Method exhibited system precision as well as intra-day precision as exemplified by % RSD of 0.570 and 0.704%, respectively. The proposed analytical method was validated for ruggedness, sensitivity, and robustness.
Conclusion: It was concluded that developed UV spectrophotometry method was accurate, precise, linear, specific, rugged, robust and sensitive and, therefore, can be used for routine analysis and quantitative estimation of NFH loaded in polymethacrylate nanospheres.
2. Kyung HK, Salahadin A. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain 2014;27:103-11.
3. Verleye M, AndrÃ© N, Heulard I, Gillardin JM. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodent. Brain Res 2004;1013:249-55.
4. Girard P, Pansart Y, CoppÃ© MC, Verniers D, Gillardin JM. Role of the histamine system in nefopam-induced antinociception in mice. Eur J Pharmacol 2004;503:63-9.
5. Podranski T, Bouillon TW, Riva-T, Kurz AM, Oehmke MJ. Compartmental pharmacokinetics of nefopam during mild hypothermia. Br J Anaesth 2012;108:784-91.
6. Lee HJ, Kim JH, Cheong YK. The analgesic effect of nefopam with fentanyl at the end of laparoscopic cholecystectomy. Korean J Pain 2013;26:361-7.
7. Starek M, Dabrowska M, Tarsa M. Analysis of nefopam by TLC-densitometry. A study of degradation mechanism in solutions under stress conditions. Acta Chim Slov 2011;58:262-9.
8. Starek M, DÄ…browska M. Development and validation of a TLC-densitometry method for quantitative analysis of nefopam hydrochloride beside its degradation products. J Anal Chem 2012;67:733-9.
9. Shama SA, Amin AS. Spectrophotometric micro determination of nefopam, mebevrine and phenylpropanolamine hydrochloride in pharmaceutical formulations using alizarins. Spectrochim Acta Part A 2004;60:1769-74.
10. Schuppan D, Hansen CS, Ober RE. GLC determination of nanogram quantities of a new analgesic, nefopam, in human plasma. J Pharm Sci 1978;67:1720-3.
11. Burton LC, Loftus NJ, Vere DW, Whelpton R. Determination of plasma nefopam by liquid chromatography and electrochemical detection. J Chromatogr 1990;526:159-68.
12. Chang LC, Wang DP. Rapid fluorimetric assay for plasma nefopam using high-performance liquid chromatography. J Liq Chromatogr Relat Technol 1994;17:1971-80.
13. Nijhu RS, Akhter DT, Jhanker YM. Development and validation of UV spectrophotometric method for quantitative estimation of nitroglycerin in pharmaceutical dosage form. Int Curr Pharm J 2011;1:1-5.
14. Singh S, Singla Y, Arora S. Statistical, diagnostic and response surface analysis of nefopam hydrochloride nanospheres using 35Box-Behnken design. Int J Pharm Pharm Sci 2015;7:89-101.
15. Nagisetty P, Kumar SMS, Kumar PR. Analytical method development and validation of anti-HIV drug abacavir sulfate. J Appl Pharm Sci 2012;2:85-9.
16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use. Validation of Analytical Procedures: Text and Methodology ICH Q2 (R1); 2005.
17. Aneesh TP, Rajasekaran A. Method development and validation for the estimation of sildosin in bulk and pharmaceutical dosage forms using UV-VIS spectrophotometry. Asian J Pharm Clin Res 2012;5:150-2.
18. Rathod BH, Rani SS, Kartheek N, Kumar AA. UV spectrophotometric method development and validation for the quantitative estimation of indinavir sulfate in capsules. Int J Pharm Pharm Sci 2014;6:598-601.
19. Rani YN, Kumar BVVR, Mohanty S. Development and validation of new analytical methods for the estimation of carvedilol in bulk and pharmaceutical dosage. Asian J Pharm Clin Res 2013;6:138-40.
20. Singh AV, Nath LK, Pani NR. Development and validation of analytical method for the estimation of lamivudine in rabbit plasma. J Pharm Anal 2011;1:251-7.